Considerations for current and future management of haemophilia and its complications

Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B

I. M. Nilsson, Erik Berntorp, Thomas Löfqvist et al. · Journal of Internal Medicine · 1992 · 968 citations

Medicine, Hematology, Pediatrics +10

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

S. Ehrenforth, W. Kreuz, R. Linde et al. · The Lancet · 1992 · 608 citations

Medicine, Hematology, Hemostasis +11

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

Jeanne M. Lusher, Steven Arkin, Charles F. Abildgaard et al. · New England Journal of Medicine · 1993 · 494 citations · Full text

Medicine, Hematology, Infectious Diseases +14

Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus Infection

Gary J. Kurtzman, Keiya Ozawa, Bernard Cohen et al. · New England Journal of Medicine · 1987 · 459 citations

Medicine, Hematology, Infectious Diseases +17

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

Bray Gl, Gomperts Ed, S Courter et al. · PubMed · 1994 · 353 citations

Medicine, Hematology, Pharmacotherapy +17